Michael E O'Dwyer (Michael O'Dwyer, M O'Dwyer)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 10

Top Venues

Blood advances

Journal of immunology research

Cancer immunology, immunotherapy : CII

Cancers

National University of Ireland - Galway

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National University of Ireland - Galway Jan 01 2007

Ireland

Professor of Haematology :: Medicine

Galway University Hospitals Jul 01 2002

Ireland

Consultant Haematologist :: Haematology

Oregon Health and Science University Jul 01 2001 - Jun 30 2002

United States

Assistant Professor :: Division of Hematology and Medical Oncology

Publications

John Daly, Subhashis Sarkar, Alessandro Natoni, Jessica C Stark, Nicholas M Riley, Carolyn R Bertozzi, Mattias Carlsten, Michael E O'Dwyer
Targeting hypersialylation in multiple myeloma represents a novel approach to enhance NK cell-mediated tumor responses. Blood advances 6 (11) (2022)
Rui Teng, Yanmeng Wang, Nan Lv, Dan Zhang, Ramone A Williamson, Lei Lei, Ping Chen, Li Lei, Baiyan Wang, Jiaqi Fu, Xuna Liu, Aili He, Jinsong Hu, Michael E O'Dwyer
Corrigendum to "Hypoxia Impairs NK Cell Cytotoxicity through SHP-1-Mediated Attenuation of STAT3 and ERK Signaling Pathways". Journal of immunology research 2021 (2021)
Daniel J DeAngelo, Brian A Jonas, Jane L Liesveld, Dale L Bixby, Anjali S Advani, Paula Marlton, John L Magnani, Helen M Thackray, Eric J Feldman, Michael E O'Dwyer, Pamela S Becker
Phase 1/2 study of uproleselan added to chemotherapy in patients with relapsed or refractory acute myeloid leukemia. Blood (2021)
Mark Gurney, Michael E O'Dwyer
Realizing Innate Potential: CAR-NK Cell Therapies for Acute Myeloid Leukemia. Cancers 13 (7) (2021)
Michael E O'Dwyer, R Henderson, S D Naicker, M R Cahill, P Murphy, Vitaliy Mykytiv, J Quinn, C McEllistrim, J Krawczyk, J Walsh, E Lenihan, T Kenny, A Hernando, G Hirakata, I Parker, E Kinsella, G Gannon, Alessandro Natoni, K Lynch, A E Ryan
CyBorD-DARA is potent initial induction for MM and enhances ADCP: initial results of the 16-BCNI-001/CTRIAL-IE 16-02 study. Blood advances 3 (12) (2020)
Steven E Coutre, John C Byrd, Peter Hillmen, Jacqueline C Barrientos, Paul M Barr, Stephen Devereux, Tadeusz Robak, Thomas J Kipps, Anna Schuh, Carol Moreno, Richard R Furman, Jan A Burger, Michael E O'Dwyer, Paolo Ghia, Rudolph Valentino, Stephen Chang, James P Dean, Danelle F James, Susan M O'Brien
Long-term safety of single-agent ibrutinib in patients with chronic lymphocytic leukemia in 3 pivotal studies. Blood advances 3 (12) (2020)
Dan Zhang, Rui Guo, Lei Lei, Hongjuan Liu, Yawen Wang, Yili Wang, Hongbo Qian, Tongxin Dai, Tianxiao Zhang, Yanjun Lai, Jingya Wang, Zhiqiang Liu, Tianyan Chen, Aili He, Michael E O'Dwyer, Jinsong Hu
Frontline Science: COVID-19 infection induces readily detectable morphologic and inflammation-related phenotypic changes in peripheral blood monocytes. Journal of leukocyte biology 109 (1) (2020)
Rui Teng, Yanmeng Wang, Nan Lv, Dan Zhang, Ramone A Williamson, Lei Lei, Ping Chen, Li Lei, Baiyan Wang, Jiaqi Fu, Xuna Liu, Aili He, Michael E O'Dwyer, Jinsong Hu
Hypoxia Impairs NK Cell Cytotoxicity through SHP-1-Mediated Attenuation of STAT3 and ERK Signaling Pathways. Journal of immunology research 2020 (2020)
Subhashis Sarkar, Sachin K S Chauhan, John Daly, Alessandro Natoni, Heather Fairfield, Robert Henderson, Emma Nolan, Dawn Swan, Jinsong Hu, Michaela R Reagan, Michael E O'Dwyer
The CD38low natural killer cell line KHYG1 transiently expressing CD16F158V in combination with daratumumab targets multiple myeloma cells with minimal effector NK cell fratricide. Cancer immunology, immunotherapy : CII 69 (3) (2020)
Dawn Swan, Kevin Lynch, Mark Gurney, Michael E O'Dwyer
Current and emerging immunotherapeutic approaches to the treatment of multiple myeloma. Therapeutic advances in hematology 10 (2019)

Michael E O'Dwyer.css-eqlu8i{font-size:small;padding-left:4px;} (Michael O'Dwyer, M O'Dwyer)

Publication Activity (10 Years)

Top Topics

Top Venues

Michael E O'Dwyer (Michael O'Dwyer, M O'Dwyer)